Cargando…
Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report
BACKGROUND: Immune thrombocytopenic purpura (ITP) is a rare autoimmune disorder that involves platelet destruction in the spleen. Eltrombopag (Promacta®), a thrombopoietin agonist, has been used in non-pregnant patients to manage ITP, but few cases of its use in pregnancy have been reported. CASE PR...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788087/ https://www.ncbi.nlm.nih.gov/pubmed/33437657 http://dx.doi.org/10.1016/j.crwh.2020.e00281 |